Article L1221-14
Victims of injury resulting from contamination by the hepatitis B or C virus or the human T-lymphotropic virus caused by a transfusion of blood products or an injection of blood-derived medicinal prod…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 2471–2480 of 69703 articles for “Art. I and II”
Victims of injury resulting from contamination by the hepatitis B or C virus or the human T-lymphotropic virus caused by a transfusion of blood products or an injection of blood-derived medicinal prod…
Labile blood products proposed for inclusion on the list referred to in 1° of article L. 1221-8 are assessed by the Agence nationale de sécurité du médicament et des produits de santé, on the basis of…
An order by the ministers responsible for health and social security sets the prices for the sale of labile blood products, with the exception of plasmas for transfusion purposes covered by 1° of arti…
The following may be prepared from blood or its components:1° Labile blood products, including in particular whole blood, plasma, the production of which does not involve an industrial process, whatev…
Any violation in a health establishment, in an army hospital or in one of the structures mentioned in 1° to 3° of article L. 1221-10 and due to the latter, of the legislative and regulatory requiremen…
Blood and blood components may be used for research purposes, whether or not they have been collected by the Etablissement Français du Sang. In this case, the research is carried out using samples tak…
No blood or its components may be collected for therapeutic use by a third party from a minor or from an adult who is the subject of a legal protection measure with representation relating to the pers…
Advertising for the substances mentioned in article L. 1221-2 is prohibited. Medical information and information intended to indicate the location of depots do not constitute advertising. By way of de…
Labile blood products intended for direct therapeutic use are stored, with a view to their distribution and issue, at the Établissement Français du Sang and at the Armed Forces Blood Transfusion Centr…
The Agence nationale de sécurité du médicament et des produits de santé may, after obtaining the opinion of the Etablissement français du sang and the armed forces blood transfusion centre, regulate t…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More